1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
38.71%
Revenue growth under 50% of 4997.T's 169.13%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
14.85%
Gross profit growth under 50% of 4997.T's 165.44%. Michael Burry would be concerned about a severe competitive disadvantage.
17.14%
EBIT growth below 50% of 4997.T's 1762.10%. Michael Burry would suspect deeper competitive or cost structure issues.
33.49%
Operating income growth under 50% of 4997.T's 1762.10%. Michael Burry would be concerned about deeper cost or sales issues.
25.25%
Net income growth under 50% of 4997.T's 1588.81%. Michael Burry would suspect the firm is falling well behind a key competitor.
25.24%
EPS growth under 50% of 4997.T's 1585.51%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
25.24%
Diluted EPS growth under 50% of 4997.T's 1585.51%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-92.89%
Negative 10Y revenue/share CAGR while 4997.T stands at 17.15%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-92.89%
Negative 5Y CAGR while 4997.T stands at 17.15%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-35.38%
Negative 3Y CAGR while 4997.T stands at 17.15%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Negative 10Y OCF/share CAGR while 4997.T stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Negative 5Y OCF/share CAGR while 4997.T is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-100.00%
Negative 3Y OCF/share CAGR while 4997.T stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
101.74%
Net income/share CAGR above 1.5x 4997.T's 11.17% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
101.74%
5Y net income/share CAGR above 1.5x 4997.T's 11.17%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-78.48%
Negative 3Y CAGR while 4997.T is 11.17%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-72.49%
Negative equity/share CAGR over 10 years while 4997.T stands at 12.87%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-72.49%
Negative 5Y equity/share growth while 4997.T is at 12.87%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
107.07%
3Y equity/share CAGR above 1.5x 4997.T's 12.87%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
12.74%
AR growth is negative/stable vs. 4997.T's 117.60%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-18.22%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.90%
Negative asset growth while 4997.T invests at 17.18%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
123.46%
BV/share growth above 1.5x 4997.T's 7.09%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-49.63%
We’re deleveraging while 4997.T stands at 49.82%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
6.35%
SG&A growth of 6.35% while 4997.T is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.